stockrowMaravai LifeSciences Holdings, Inc.
MRVI Healthcare Biotechnology
Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024.
- Revenue
- +10.1%
- EPS
- +50.0%
- Free cash flow
- +123.9%
- Total debt
- −45.4%
Quarter to September 2026, against a year earlier
Follow MRVI
Alert me
Maravai LifeSciences Holdings, Inc. (MRVI) Revenue growth
Maravai LifeSciences Holdings, Inc.'s revenue growth over the twelve months to 30 September 2026 was 10.7%, up 39.0 percentage points from fiscal 2025 (−28.3%). Over the past ten years it has ranged from −67.3% (fiscal 2023) to 181.3% (fiscal 2021); the current reading is higher than 25% of that period. That is above the Biotechnology industry median of 6.76% and above the Healthcare sector median of 7.98%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −28.3% | (18.04) |
| FY2024 | −10.3% | 56.98 |
| FY2023 | −67.3% | (77.76) |
| FY2022 | 10.5% | (170.85) |
| FY2021 | 181.3% | 82.85 |
| FY2020 | 98.5% | 82.89 |
| FY2019 | 15.6% | 29.08 |
| FY2018 | −13.5% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 10.1% | 1.61 |
| Jun 2026 | 8.53% | (32.00) |
| Mar 2026 | 40.5% | 52.36 |
| Dec 2025 | −11.8% | 27.86 |
| 24 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| VIR Vir Biotechnology, Inc. compare | 1,696.0% |
| HRMY Harmony Biosciences Holdings, Inc. compare | 19.8% |
| MRVI Maravai LifeSciences Holdings, Inc. | 10.7% |
| SRPT Sarepta Therapeutics, Inc. compare | −19.0% |
| MESO Mesoblast Limited compare | −26.5% |
| TRVI Trevi Therapeutics, Inc. compare | — |
| MAZE Maze Therapeutics, Inc. compare | — |
| TRAX First Tracks Biotherapeutics, Inc. compare | — |
| REPL Replimune Group, Inc. compare | — |
| Biotechnology industry median | 6.76% |
| Healthcare sector median | 7.98% |
| Market median | 7.71% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|